Author:
Kopciuch Dorota,Kus Krzysztof,Niśkiewicz Izabela,Fliciński Jędrzej,Zaprutko Tomasz,Ratajczak Piotr,Nowakowska Elżbieta,Hoffmann Karolina,Koligat-Seitz Agnieszka,Bryl Wiesław,Paczkowska Anna
Abstract
Abstract
Objectives
To compare the pediatric neurologists’ knowledge, practice, and barriers to the pharmacovigilance (PV) process in Poland and Germany.
Methods
The research tool was an online anonymous questionnaire on Google Forms e-mailed to pediatric neurologists from Poland and Germany.
Results
The questionnaires were handed out to 830 pediatric neurologists and 371 expressed their consent to participate in the study. Most of the neurologists were familiar with the definition of PV and adverse drug reactions (ADRs). Only 34.10% of pediatric neurologists from Poland, and 38.88% from Germany believe that many ADRs are preventable and almost most of them believe it is necessary to report ADRs from children with epilepsy. Unfortunately, in opposite to this knowledge, only 37.79% of respondents from Poland and 40.32% from Germany felt co-responsible for reporting ADRs. The main reason for the neurologists not to report ADRs was a conviction that reporting ADRs would be an additional burden generating extra work.
Conclusion
There is no big difference between the practice of PV by pediatric neurologists in Poland and Germany. System-regulated PV stabilization in the country translates into the practice of maintaining PV. Monitoring the safety of pharmacotherapy and knowledge of risks associated with ADRs should be included in the curricula of academic neurologics courses.
Publisher
Springer Science and Business Media LLC
Subject
Education,General Medicine
Reference31 articles.
1. Suman A. Study of adverse drug effects of antiepileptic drugs used in pediatric patients in a tertiary care rural hospital – a pharmacovigilance study. J Young Pharm. 2017;9:60–4.
2. World Health Organization. The importance of pharmacovigilance: safety monitoring of medicinal products. WHO Collaborating Centre for International Drug Monitoring [Internet]. 2002. Available from: http://apps.who.int/medicinedocs/en/d/Js4893e/.
3. Wu WK, Pantaleo N. Evaluation of outpatient adverse drug reactions leading to hospitalization. Am J Health Syst Pharm. 2003;60:253–9.
4. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42:1017–25.
5. World Health Organization, Geneva) IC for the NR of the IC of D. (1975: Manual of the international statistical classification of diseases, injuries, and causes of death : based on the recommendations of the ninth revision conference, 1975, and adopted by the Twenty-ninth World Health Assembly [Internet]. World Health Organization; 1977. Available from: https://apps.who.int/iris/handle/10665/40492.